Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Receivables (2016 - 2025)

Skinvisible (SKVI) has disclosed Receivables for 15 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • Quarterly Receivables changed 0.0% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $5000.0 for FY2025, 0.0% changed from the prior year.
  • Receivables hit $5000.0 in Q4 2025 for Skinvisible, roughly flat from $5000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $26592.0 in Q4 2023 to a low of $82.0 in Q4 2021.
  • Historically, Receivables has averaged $6246.0 across 5 years, with a median of $5000.0 in 2022.
  • Biggest five-year swings in Receivables: plummeted 98.94% in 2021 and later surged 23159.76% in 2022.
  • Year by year, Receivables stood at $82.0 in 2021, then soared by 23159.76% to $19073.0 in 2022, then surged by 39.42% to $26592.0 in 2023, then plummeted by 81.2% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Business Quant data shows Receivables for SKVI at $5000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.